Purpose Breast lesions classified as of “uncertain malignant potential” represent a
heterogeneous group of abnormalities with an increased risk of associated malignancy …

Background and aim The use of conventional needle core biopsy for palpable masses and
vacuum-assisted needle core biopsy for microcalcifications has significantly increased the …

Purpose To investigate clinical, radiologic and pathologic features of B3 lesions diagnosed
on VABB targeting microcalcifications, for identifying predictors of malignancy. Method This …

Introduction High-risk or B3 breast lesions are considered lesions of uncertain malignant
potential and comprise between 5 and 12% of initial biopsy results. We sought to perform a …

Objectives Traditionally B3 breast lesions are treated surgically, but overtreatment is a
concern, as the majority have a final benign diagnosis. A national screening program …

Aims In patients presenting with a breast lesion, when initial core biopsy histology falls into
the category of “uncertain malignant potential”(ie a B3 lesion), the next line of investigation …

Percutaneous core biopsy (CB) has been introduced to increase the ability of accurately
diagnosing breast malignancies without the need of resorting to surgery. Compared to …

Background: The question of how to deal with B3 lesions is of emerging interest. Methods: In
the breast diagnostics of 192 patients between 2009 and 2016, a minimally invasive biopsy …

The purpose of this study is to obtain a consensus for the therapy of B3 lesions. The first
International Consensus Conference on lesions of uncertain malignant potential in the …

Introduction Lesions of uncertain malignant potential (B3) represent a heterogeneous group
with an overall risk for malignancy of 9.85–35.1% after total resection. Positive predictive …